Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence
Journal: Studies on Stem Cells Research and Therapy (Vol.3, No. 1)Publication Date: 2017-04-01
Authors : Elgin OZKAN Mine ARAZ Cigdem SOYDAL; Gulseren ARAS;
Page : 001-005
Keywords : Renal cell carcinoma; Recurrent disease; 18F-FDG PET/CT; CeCT;
Abstract
Aim: To compare the results of fl uorine-18 (¹8F) fl uorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and contrast enhanced computed tomography (ceCT) in the assessment of renal cell carcinoma (RCC) recurrences when ceCT had suspected lesions for local recurrence and/or distant metastases.
Other Latest Articles
- Expectations of Epigenetic Research Studies Focusing on Mesenchymal Stem Cells
- Stem Cell Therapy for Neurodegenerative Diseases
- Human Umbilical Cord Mesenchymal Stem Cells Suppress Systemic Lupus Erythematosus Lesions by Rebalancing CD4+/CD8+ Cell Population
- Stem Cells in the Oral Cavity
- Mesenchymal Stem Cell as a Vector for Gene and Cell therapy Strategies
Last modified: 2019-04-25 18:59:45